Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon System

1 May 2003

Abstract excerpt

The use of type I interferon (IFN), in combination with ribvirin, to treat chronic hepatitis C virus (HCV) infection has many drawbacks that prevent widespread application, ultimately leading to a significant unmet clinical need. Potential improvements in IFN therapy through targeted delivery, molecular alteration, and combination with other agents are ongoing in an attempt to decrease adverse effects and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Hepatitis C virus research
Share to Systemic Lupus Erythematosus Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12804067
DOI: 10.1089/107999003321829962

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon SystemPMID 12804067Read ↗

Searching for synergy: Identifying optimal antiviral combination therapy using Hepatitis C virus (HCV) agents in a replicon system.Semantic proximity Read ↗

Synergistic Inhibition of Intracellular Hepatitis C Virus Replication by Combination of Ribavirin and Interferon‐αSemantic proximity Read ↗

Independent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human FibroblastsSemantic proximity Read ↗

Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture modelsSemantic proximity Read ↗

Global Transcriptional Profiling Demonstrates the Combination of Type I and Type II Interferon Enhances Antiviral and Immune Responses at Clinically Relevant DosesSemantic proximity Read ↗

Novel type I interferon IL-28A suppresses hepatitis C viral RNA replicationSemantic proximity Read ↗

Modeling Suggests a Mechanism of Synergy Between Hepatitis C Virus Entry Inhibitors and Drugs of Other ClassesSemantic proximity Read ↗

Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 2 and high virus load.Semantic proximity Read ↗

Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.Semantic proximity Read ↗

The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.Semantic proximity Read ↗

[Combination therapy of interferon plus ribavirin for chronic hepatitis C].Semantic proximity Read ↗

Ribavirin and interferon-β synergistically inhibit SARS-associated coronavirus replication in animal and human cell linesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.